BluePath Capital Management’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
Other funds holding LRCX
BluePath Capital Management's LRCX Position: Q4 2023 in Review
BluePath Capital Management sold out of Lam Research (LRCX) in Q4 2023, closing a stake of 440 shares — an estimated $27.6K sold.
BluePath Capital Management first reported a position in LRCX in Q3 2023 and held it in 1 quarter. The position peaked at $27.6K in Q3 2023. 1,630 funds tracked by Wall St. Rank hold LRCX as of Q4 2023.
- BluePath Capital Management reported no remaining Lam Research position as of Q4 2023 after selling out during the quarter.
- BluePath Capital Management sold 440 Lam Research shares in Q4 2023, an estimated $27.6K.
- BluePath Capital Management first reported a position in Lam Research in Q3 2023 and held it in 1 quarter.
- BluePath Capital Management's Lam Research position peaked at $27.6K in Q3 2023.
- 1,630 funds tracked by Wall St. Rank held Lam Research as of Q4 2023.
Based on BluePath Capital Management's 13F filing for Q4 2023, filed 11 Jan 2024.